Artykuły w czasopismach: „Pathogenic”

1

Gvozdyak, R. I. "«Pathogen-1» Experiment Aggression of pathogenic bacteria in microgravity". Kosmìčna nauka ì tehnologìâ 6, nr 4 (30.07.2000): 111. http://dx.doi.org/10.15407/knit2000.04.119.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Ruchel, Reinhard. "Proteinasen pathogener Pilze: Proteinases of pathogenic fungi". Mycoses 42, S1 (kwiecień 1999): 48–52. http://dx.doi.org/10.1111/j.1439-0507.1999.tb04527.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Gharwalova, Lucia, Marketa Kulisova, Anastasiia Vasyliuk, Helena Maresova, Andrea Palyzova, Linda Nedbalova i Irena Kolouchova. "Sphingolipids of plant pathogenic fungi". Plant Protection Science 57, No. 2 (1.03.2021): 134–39. http://dx.doi.org/10.17221/131/2020-pps.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

Glycosphingolipids in filamentous fungi are significant components of the plasma membrane and are vital for different cellular processes, such as growth, morphological transition or signal transduction. Fungal growth inhibitors targeting glycosylinositolphosphoceramide (GIPCs) biosynthesis or antifungal compounds binding to GIPCs present in membranes could present a safe way of preventing fungal growth on crops since GIPCs are not present in mammalian cells. Mass spectrometry-based shotgun lipidomics was used to analyze sphingolipids of 11 fungal strains isolated from plant material. Molecular species with inositol ceramides containing zero to five carbohydrates were identified. Differences in the amount of individual molecular species were influenced by the taxonomic affiliation. All tested strains exhibited a relatively high content (more than 40 mol.%) of GIPCs with three and more saccharides attached to the polar head. It could be assumed that the sphingolipid profiles of the tested plant pathogens would be an adaptation mechanism to antifungal plant defensins.

4

Finn, Albert F., i Peter D. Gorevic. "Pathogenic paraproteins". Current Opinion in Rheumatology 2, nr 4 (sierpień 1990): 652–60. http://dx.doi.org/10.1097/00002281-199002040-00017.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Horvat, Rebecca T. "PATHOGENIC FUNGI". Shock 30, nr 6 (grudzień 2008): 753. http://dx.doi.org/10.1097/01.shk.0000336210.36795.86.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Gould, EA, i T. Solomon. "Pathogenic flaviviruses". Lancet 371, nr 9611 (luty 2008): 500–509. http://dx.doi.org/10.1016/s0140-6736(08)60238-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

DIPERRI, G. "PATHOGENIC ENTAMOEBA". Lancet 331, nr 8595 (maj 1988): 1166. http://dx.doi.org/10.1016/s0140-6736(88)91980-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Gao, Shou-Jiang. "Pathogenic procedures". Trends in Microbiology 5, nr 3 (marzec 1997): 125–26. http://dx.doi.org/10.1016/s0966-842x(97)87506-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Tran Van Nhieu, Guy. "Pathogenic paradox?" Trends in Microbiology 7, nr 3 (marzec 1999): 102. http://dx.doi.org/10.1016/s0966-842x(99)01473-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Casci, Tanita. "Pathogenic conversions". Nature Reviews Genetics 13, nr 1 (16.12.2011): 2. http://dx.doi.org/10.1038/nrg3143.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Dempsey, Laurie A. "Pathogenic antibodies". Nature Immunology 20, nr 11 (22.10.2019): 1414. http://dx.doi.org/10.1038/s41590-019-0535-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

POOLMAN, J. "Pathogenic neisseriae". Lancet 336, nr 8722 (październik 1990): 1061. http://dx.doi.org/10.1016/0140-6736(90)92518-m.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Prasanna, Arun N., i Sarika Mehra. "Comparative Phylogenomics of Pathogenic and Non-Pathogenic Mycobacterium". PLoS ONE 8, nr 8 (28.08.2013): e71248. http://dx.doi.org/10.1371/journal.pone.0071248.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Foley, J. F. "Detecting a Pathogenic Activity, Not a Pathogenic Molecule". Science Signaling 7, nr 343 (16.09.2014): ec252-ec252. http://dx.doi.org/10.1126/scisignal.2005897.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Thongboonkerd, Visith, Wararat Chiangjong, Putita Saetun, Supachok Sinchaikul, Shui-Tein Chen i Uraiwan Kositanont. "Analysis of differential proteomes in pathogenic and non-pathogenic Leptospira : Potential pathogenic and virulence factors". PROTEOMICS 9, nr 13 (lipiec 2009): 3522–34. http://dx.doi.org/10.1002/pmic.200700855.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Bøe, Johs. "On the Distinction Between Pathogenic and Non-Pathogenic Staphylococci". Acta Pathologica Microbiologica Scandinavica 21, nr 5 (14.08.2009): 721–30. http://dx.doi.org/10.1111/j.1699-0463.1944.tb04972.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Wurtzel, Omri, Nina Sesto, J. R. Mellin, Iris Karunker, Sarit Edelheit, Christophe Bécavin, Cristel Archambaud, Pascale Cossart i Rotem Sorek. "Comparative transcriptomics of pathogenic and non‐pathogenic Listeria species". Molecular Systems Biology 8, nr 1 (styczeń 2012): 583. http://dx.doi.org/10.1038/msb.2012.11.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

DiMiceli, Lauren. "Distinguishing Between Pathogenic and Non-Pathogenic Species of Entamoeba". Laboratory Medicine 35, nr 10 (1.10.2004): 613–15. http://dx.doi.org/10.1309/b81npvaw8y4bgy11.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Roberts, Glenn D. "Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes". Mayo Clinic Proceedings 63, nr 10 (październik 1988): 1061–62. http://dx.doi.org/10.1016/s0025-6196(12)64931-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Prasad, Rajendra, Frédéric Devaux, Sanjiveeni Dhamgaye i Dibyendu Banerjee. "Response of pathogenic and non-pathogenic yeasts to steroids". Journal of Steroid Biochemistry and Molecular Biology 129, nr 1-2 (marzec 2012): 61–69. http://dx.doi.org/10.1016/j.jsbmb.2010.11.011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Hopsu-Havu, V. K., C. E. Sonck i Elvi Tunnela. "Production of Elastase by Pathogenic and Non-Pathogenic Fungi". Mycoses 15, nr 3 (24.04.2009): 105–10. http://dx.doi.org/10.1111/j.1439-0507.1972.tb01357.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Ahearn, Donald G. "Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes". JAMA: The Journal of the American Medical Association 260, nr 12 (23.09.1988): 1794. http://dx.doi.org/10.1001/jama.1988.03410120140051.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Gaminda, K. A. P. "DEOXYRIBOZYMES IN DETECTION OF PATHOGENIC BACTERIA". Biotechnologia Acta 14, nr 5 (październik 2021): 5–20. http://dx.doi.org/10.15407/biotech14.05.005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

Aim. The purpose of the review was to analyze the use of DNAzyme biosensors for the detection of pathogens. In the recent years, deoxyribozymes (DNAzymes) have a significant impact as biosensors in diverse fields, from detection of metal ions in the environment to theranostic applications and detection of microorganisms. Although routinely used sophisticated instrumental methods are available to detect pathogenic bacterial contamination, they involve time-consuming, complicated sample pre-treatment and expensive instruments. As an alternative, pathogen-specific DNAzymes have demonstrated a series of advantages: a non-destructive rapid analysis technique with in situ and real-time detection of bacteria with high sensitivity and selectivity. A wide range of pathogen-specific DNAzymes has been developed using colorimetric and fluorescence-based detections for pathogenic bacterial contamination in various samples. The current review summarizes the in vitro selection of pathogen-specific DNAzymes, various strategies utilized in the sensor designs, and their potential use in theranostic applications.

24

Orlyankin, B. G., i T. I. Aliper. "Porcine pathogenic viruses". "Veterinary Medicine" Journal 23, nr 01 (styczeń 2020): 03–08. http://dx.doi.org/10.30896/0042-4846.2020.23.1.03-08.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Kaper, James B., James P. Nataro i Harry L. T. Mobley. "Pathogenic Escherichia coli". Nature Reviews Microbiology 2, nr 2 (luty 2004): 123–40. http://dx.doi.org/10.1038/nrmicro818.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Parkhill, Julian, i Colin Berry. "Relative pathogenic values". Nature 423, nr 6935 (maj 2003): 23–24. http://dx.doi.org/10.1038/423023a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Suerbaum, Sebastian, i Torkel Wadström. "Bacterial pathogenic factors". Current Opinion in Gastroenterology 11 (1995): 11–15. http://dx.doi.org/10.1097/00001574-199501001-00003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Figura, Natale, i Soad Tabaqchali. "Bacterial pathogenic factors". Current Opinion in Gastroenterology 12 (styczeń 1996): 11–15. http://dx.doi.org/10.1097/00001574-199601001-00003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Bisel, Ryan S., i Debra J. Ford. "Diagnosing Pathogenic Eschatology". Communication Studies 59, nr 4 (21.11.2008): 340–54. http://dx.doi.org/10.1080/10510970802467395.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Charlotte, Harrison. "Identifying pathogenic pathways". Nature Reviews Drug Discovery 12, nr 7 (lipiec 2013): 506. http://dx.doi.org/10.1038/nrd4061.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Barešić, Anja, i Andrew C. R. Martin. "Compensated pathogenic deviations". BioMolecular Concepts 2, nr 4 (1.08.2011): 281–92. http://dx.doi.org/10.1515/bmc.2011.025.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

AbstractDeleterious or ‘disease-associated’ mutations are mutations that lead to disease with high phenotype penetrance: they are inherited in a simple Mendelian manner, or, in the case of cancer, accumulate in somatic cells leading directly to disease. However, in some cases, the amino acid that is substituted resulting in disease is the wild-type native residue in the functionally equivalent protein in another species. Such examples are known as ‘compensated pathogenic deviations’ (CPDs) because, somewhere in the second species, there must be compensatory mutations that allow the protein to function normally despite having a residue which would cause disease in the first species. Depending on the nature of the mutations, compensation can occur in the same protein, or in a different protein with which it interacts. In principle, compensation can be achieved by a single mutation (most probably structurally close to the CPD), or by the cumulative effect of several mutations. Although it is clear that these effects occur in proteins, compensatory mutations are also important in RNA potentially having an impact on disease. As a much simpler molecule, RNA provides an interesting model for understanding mechanisms of compensatory effects, both by looking at naturally occurring RNA molecules and as a means of computational simulation. This review surveys the rather limited literature that has explored these effects. Understanding the nature of CPDs is important in understanding traversal along fitness landscape valleys in evolution. It could also have applications in treating diseases that result from such mutations.

32

Jauniaux, E. "I158 PATHOGENIC MECHANISMS". International Journal of Gynecology & Obstetrics 119 (październik 2012): S199—S200. http://dx.doi.org/10.1016/s0020-7292(12)60188-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Angell, E. "Pathogenic waste treatment". Environment International 23, nr 3 (1997): IX—X. http://dx.doi.org/10.1016/s0160-4120(97)88023-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Kaper, James B. "Pathogenic Escherichia coli". International Journal of Medical Microbiology 295, nr 6-7 (październik 2005): 355–56. http://dx.doi.org/10.1016/j.ijmm.2005.06.008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Fattakhov, R. "Genesis pathogenic ecosystems". Parasitology International 47 (sierpień 1998): 329. http://dx.doi.org/10.1016/s1383-5769(98)80967-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Bahcall, Orli G. "Classifying pathogenic variation". Nature Reviews Genetics 16, nr 3 (18.02.2015): 131. http://dx.doi.org/10.1038/nrg3915.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Holmes, Edward C. "Virology: Pathogenic passengers". Nature 478, nr 7369 (październik 2011): 319–20. http://dx.doi.org/10.1038/478319a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Shoenfeld, Yehuda. "Pathogenic natural autoantibodies". Clinical Immunology Newsletter 13, nr 2-3 (luty 1993): 13–19. http://dx.doi.org/10.1016/0197-1859(93)90020-k.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Wackett, Lawrence P. "Plant pathogenic microorganisms". Environmental Microbiology 17, nr 10 (październik 2015): 4143–44. http://dx.doi.org/10.1111/1462-2920.13067.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Kiberstis, P. A. "NEUROSCIENCE: Pathogenic Tangles". Science 287, nr 5462 (31.03.2000): 2377f—2377. http://dx.doi.org/10.1126/science.287.5462.2377f.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Voelkner, Nadine. "Managing pathogenic circulation". Security Dialogue 42, nr 3 (czerwiec 2011): 239–59. http://dx.doi.org/10.1177/0967010611405393.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Broder, Samuel. "Pathogenic Human Retroviruses". New England Journal of Medicine 318, nr 4 (28.01.1988): 243–45. http://dx.doi.org/10.1056/nejm198801283180409.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

H., G. C., i J. A. von Arx. "Plant Pathogenic Fungi". Mycologia 79, nr 6 (listopad 1987): 919. http://dx.doi.org/10.2307/3807701.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

van West, Pieter, i Gordon W. Beakes. "Animal pathogenic Oomycetes". Fungal Biology 118, nr 7 (lipiec 2014): 525–26. http://dx.doi.org/10.1016/j.funbio.2014.05.004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Harborne, Jeffrey B. "Plant pathogenic bacteria". Phytochemistry 27, nr 5 (styczeń 1988): 1569–70. http://dx.doi.org/10.1016/0031-9422(88)80251-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Calam, John. "4 Pathogenic mechanisms". Baillière's Clinical Gastroenterology 9, nr 3 (wrzesień 1995): 487–506. http://dx.doi.org/10.1016/0950-3528(95)90044-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Solbrig, Marylou V. "Human pathogenic arenaviruses". Annals of Neurology 64, nr 3 (25.02.2008): 355–56. http://dx.doi.org/10.1002/ana.21350.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Filip, Z., D. Kaddu-Mulindwa i G. Milde. "Survival of Some Pathogenic and Facultative Pathogenic Bacteria in Groundwater". Water Science and Technology 20, nr 3 (1.03.1988): 227–31. http://dx.doi.org/10.2166/wst.1988.0105.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

In model experiments carried out in the laboratory the survival of bacteria in groundwater kept at 10±l °C was tested. Only two of the tested bacteria species did not survive longer than 10 - 30 days. Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa and other pathogenic or facultative pathogenic bacteria survived up to 100 days or even more in ground-water with or without the addition of sand from an aquifer. These results can be of importance for determining groundwater protection zones.

49

Napalkova, G. M., I. I. Korsakova, N. P. Khrapova, N. N. Piven', L. V. Lomova i T. V. Bulatova. "Differentiation of Pathogenic and Non-Pathogenic Burkholderias Using Rocket Immunoelectrophoresis". Problems of Particularly Dangerous Infections, nr 4(106) (20.08.2010): 37–38. http://dx.doi.org/10.21055/0370-1069-2010-4(106)-37-38.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenie:

Demostrated is the possibility to differentiate virulent strains of melioidosis and glanders etiological agents from avirulent ones and closely related microorganisms according to the presence of the antigenic complex 8, using rocket immunoelectrophoresis with the serum containing antibodies to this complex.

50

Korva, Miša, Nataša Knap, Katarina Rus, Luka Fajs, Gašper Grubelnik, Matejka Bremec, Tea Knapič, Tomi Trilar i Tatjana Županc. "Phylogeographic Diversity of Pathogenic and Non-Pathogenic Hantaviruses in Slovenia". Viruses 5, nr 12 (10.12.2013): 3071–87. http://dx.doi.org/10.3390/v5123071.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Artykuły w czasopismach na temat „Pathogenic”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych